PuSH - Publikationsserver des Helmholtz Zentrums München: Inborn error of immunity or atopic dermatitis: When to be concerned and how to investigate.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Stadler, P.C.* ; Renner, E.D. ; Milner, J.* ; Wollenberg, A.*

Inborn error of immunity or atopic dermatitis: When to be concerned and how to investigate.

J. Allergy Clin. Immunol. 9, 1501-1507 (2021)

DOI

PMC

Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.

Abstract
Metriken
Zusatzinfos

Around 20% of all children worldwide suffer from Atopic Dermatitis (AD). Therefore, eczematous skin lesions and elevated serum Immunglobulin E (IgE) levels are common findings. Inborn Errors of Immunity (IEI) may be missed in the context of AD, and management and prognosis of these conditions can be substantially different. Children suffering from IEIs such as Hyper-IgE-Syndromes (HIES), Wiskott-Aldrich-syndrome (WAS), Immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, Omenn syndrome, the atypical complete DiGeorge syndrome and skin barrier disorders like Comèl-Netherton-syndrome and Severe-dermatitis-multiple-allergies-and-metabolic-wasting (SAM) syndrome may present with additional "red flags", which should raise a clinical suspicion for an underlying IEI. These "red flags" may include eczematous skin lesion manifesting prior to two month of life, disseminated or recurrent viral, bacterial or fungal infections, mucocutaneous candidiasis, purpura, chronic diarrhea, or abnormalities in development or of connective tissue. A differential blood count, as well as a lymphocyte subset analysis, total immunoglobulin levels and vaccination titers can help the clinician to decide whether a patient with eczematous skin lesions and elevated serum IgE should be referred to a clinical immunologist for a full immunologic work-up and broad genetic analysis.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

10.793

0.000